Epicriptine
Jump to navigation
Jump to search
Clinical data | |
---|---|
Other names | beta-Dihydroergocryptine |
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.039.157 |
Chemical and physical data | |
Formula | C32H43N5O5 |
Molar mass | 577.726 g·mol−1 |
3D model (JSmol) | |
| |
|
Epicriptine or beta-dihydroergocryptine is a dopamine agonist of the ergoline class. It constitutes one third of the mixture known as dihydroergocryptine, the other two thirds consisting of alpha-dihydroergocryptine. The alpha differs from the beta form only in the position of a single methyl group, which is a consequence of the biosynthesis in which the proteinogenic amino acid isoleucine is replaced by leucine.[1]
References
- ^ Steinhilber D, Schubert-Zsilavecz M, Roth HJ (2005). Medizinische Chemie (in German). Stuttgart: Deutscher Apotheker Verlag. p. 142. ISBN 3-7692-3483-9.
Categories:
- CS1 German-language sources (de)
- Articles with short description
- Short description matches Wikidata
- Drugs with non-standard legal status
- ECHA InfoCard ID from Wikidata
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles containing unverified chemical infoboxes
- Dopamine agonists
- Oxazolopyrrolopyrazines
- Lactams
- Ergot alkaloids
- Lysergamides
- Isopropyl compounds
- All stub articles
- Nervous system drug stubs